The association between thoracic periaortic fat and major adverse cardiovascular events

Thoracic periaortic fat tissue volume may be considered a useful new parameter for predicting major adverse cardiovascular events.

The association between thoracic periaortic fat and major adverse cardiovascular events

The association between thoracic periaortic fat and major adverse cardiovascular events

  • Zeynettin Kaya MD, 
  • Seref Ulucan, 
  • MehmetKayrak, 
  • Omer Akyurek, 
  • Huseyin Katlandur, 
  • Ahmet Keser, 
  • Duran Efe, 
  • Huseyin Ozdil & 
  • Mehmet S. Ulgen 

Wiener klinische Wochenschrift volume 127, pages191–196 (2015)Cite this article

  • 191 Accesses

  • 2 Citations

  • 1 Altmetric

  • Metricsdetails

Abstract

Aim

The study aimed to examine the association between thoracic periaortic fat tissue volume and the long-term incidence of major adverse cardiovascular events.

Methods

This retrospective cohort study included 433 consecutive patients (372 male and 61 female). Periaortic fat tissue volume was measured via electrocardiogram-gated 64-multidetector computed tomography. The patients were evaluated on an average 3 years of follow-up for major adverse cardiovascular events. The patients were divided into groups according to the presence of major adverse cardiovascular events.

Results

Major adverse cardiovascular events were noted in 44 (10.2 %) patients during follow-up. Periaortic fat tissue volume was significantly higher in the major adverse cardiovascular events (+) group (35.4 ± 26.1 cm3 vs. 24.1 ± 14.9 cm3, P = 0.001). The logistic regression model showed that periaortic fat tissue volume (hazard ratio: 1.03; 95 % CI: 1.01–1.05; P = 0.001), the glomerular filtration rate (hazard ratio: 0.98; 95 % CI: 0.96–0.99; P = 0.03), and male gender (hazard ratio: 4.76; 95 % CI: 1.08–20.90; P = 0.04) were independent predictors of major adverse cardiovascular events.

Conclusion

Thoracic periaortic fat tissue volume may be considered a useful new parameter for predicting major adverse cardiovascular events.

This is a preview of subscription content, access via your institution.

References

  1. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb. 2010;17:115–30.

    Article CAS PubMed Google Scholar 

  2. Lee H-Y, Després J-P, Koh KK. Perivascular adipose tissue in the pathogenesis of cardiovascular disease. Atherosclerosis. 2013;230:177–84.

    Article CAS PubMed Google Scholar 

  3. Lehman SJ, Massaro JM, Schlett CL, O’Donnell CJ, Hoffmann U, Fox CS. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis. 2010;210:656–61.

    Article PubMed Central CAS PubMed Google Scholar 

  4. Cheng K-H, Chu C-S, Lee K-T, Lin T-H, Hsieh C-C, Chiu C-C, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes. 2008;32:268–74.

  5. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27:996–1003.

    Article CAS PubMed Google Scholar 

  6. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand. 2005;184:285–93.

    Article CAS PubMed Google Scholar 

  7. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2009;22:1311–9; quiz 1417–8.

  8. Klopfenstein BJ, Kim MS, Krisky CM, Szumowski J, Rooney WD, Purnell JQ. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol. 2012;85:e826–30.

    Article PubMed Central CAS PubMed Google Scholar 

  9. Fox CS, Massaro JM, Schlett CL, Lehman SJ, Meigs JB, O’Donnell CJ, et al. Periaortic fat deposition is associated with peripheral arterial disease: the Framingham heart study. Circ Cardiovasc Imaging. 2010;3:515–9.

    Article PubMed Central PubMed Google Scholar 

  10. Thanassoulis G, Massaro JM, Corsini E, Rogers I, Schlett CL, Meigs JB, et al. Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc. 2012;1:e000885.

    Article PubMed Central PubMed Google Scholar 

  11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.

    Article CAS PubMed Google Scholar 

  12. Chityala R, Hoffmann KR, Bednarek DR, Rudin S. Region of Interest (ROI) Computed Tomography. Proc Soc Photo-Opt Instrum Eng. 2004;5368:534–41.

    PubMed Central PubMed Google Scholar 

  13. Taylor J. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2506–7.

    Article PubMed Google Scholar 

  14. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A–13A.

    Article CAS PubMed Google Scholar 

  15. Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2013;32(1):38–8.

    Google Scholar 

  16. Gu P, Jiang W, Lu B, Shi Z. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients. Clin Exp Hypertens NY 1993. 2013;36(5):326–32.

  17. Diaz-Melean CM, Somers VK, Rodriguez-Escudero JP, Singh P, Sochor O, Llano EM, et al. Mechanisms of adverse cardiometabolic consequences of obesity. Curr Atheroscler Rep [Internet]. 2013[kaynak 27 Eylül 2013];15. Tarihinde adresinden eris¸ ildi: http://link.springer.com/10.1007/s11883-013-0364-2.

  18. Kammoun HL, Kraakman MJ, Febbraio MA. Adipose tissue inflammation in glucose metabolism. Rev Endocr Metab Disord. 2013;15(1):31–44.

    Article Google Scholar 

  19. Gröber-Grätz D, Widhalm K, de Zwaan M, Reinehr T, Blüher S, Schwab KO, et al. Body mass index or waist circumference: which is the better predictor for hypertension and dyslipidemia in overweight/obese children and adolescents? Association of cardiovascular risk related to body mass index or waist circumference. Horm Res Paediatr. 2013;80(3):170–8.

  20. Jolly US, Soliman A, McKenzie C, Peters T, Stirrat J, Nevis I, et al. Intra-thoracic fat volume is associated with myocardial infarction in patients with metabolic syndrome. J Cardiovasc Magn Reson 2013;15:77.

    Article PubMed Central PubMed Google Scholar 

  21. Karastergiou K, Fried SK. Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr Atheroscler Rep. [Internet]. 2013[kaynak 25 Eylül 2013];15. Tarihinde adresinden eris¸ ildi: zotero://attachment/91/

  22. Gastaldelli A, Basta G. Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc Dis NMCD. 2010;20:481–90.

    Article CAS Google Scholar 

  23. Britton KA, Wang N, Palmisano J, Corsini E, Schlett CL, Hoffmann U, et al. Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function: thoracic periaortic fat and vascular function. Obesity. 2013;21:1496–503.

    Article PubMed Central PubMed Google Scholar 

  24. Baker AR, Silva NF da, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.

    Article PubMed Central PubMed Google Scholar 

  25. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11:304–10.

    Article PubMed Google Scholar 

  26. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–8.

    Article CAS PubMed Google Scholar 

  27. Iacobellis G, Leonetti F, Singh N, M Sharma A. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007;115:272–3.

    Article PubMed Google Scholar 

  28. Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:781–6.

    Article CAS PubMed Google Scholar 

  29. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obes Silver Spring Md. 2008;16:887–92.

    Article Google Scholar 

  30. Flüchter S, Haghi D, Dinter D, Heberlein W, Kühl HP, Neff W, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obes Silver Spring Md. 2007;15:870–8.

    Article Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Mevlana University, Yeni İstanbul Cad. No: 235, 42003, Selçuklu, Konya, Turkey

    Zeynettin Kaya MD,  Seref Ulucan,  Huseyin Katlandur,  Ahmet Keser,  Huseyin Ozdil &  Mehmet S. Ulgen

  2. Department of Cardiology, Necmettin Erbakan University, Konya, Turkey

    MehmetKayrak

  3. Department of Internal Medicine, Mevlana University, Konya, Turkey

    Omer Akyurek

  4. Department of Radiology, Mevlana University, Konya, Turkey

    Duran Efe

Bu makale 10 Ocak 2023 tarihinde güncellendi. 0 kez okundu.

Yazar
Doç. Dr. Şeref Ulucan

Uzm.Dr. Şeref ULUCAN, 15 Eylül 1968 tarihinde doğmuştur. Lisans öncesi öğrenimlerinin ardından Erciyes Üniversitesi Tıp Fakültesi'nde başladığı tıp eğitimini başarıyla tamamlayarak 1993 yılında tıp doktoru unvanı almıştır. İhtisasını ise Selçuk Üniversitesi Tıp Fakültesi'nde  yapmış ve 1997 yılında Kardiyoloji Uzmanı olmuştur. 

Uzmanlık eğitimi sonrasında, 1998-2012 yılları arası Özel Konya Vakıf Hastanesi'nde, 2012-2016 yılları arası Mevlana Üniversitesi Hastanesi'nde ve 2017 - 2022 yılları arasında Kayseri Özel Tekden Hastanesi'nde çalışmalarını sürdürmüştür.

 

Şu anda  Konya Özel Büyükşehir Hastanesi'nde hasta kabul etmektedir.

Doç. Dr. Şeref Ulucan
Doç. Dr. Şeref Ulucan
Konya - Kardiyoloji
Facebook Twitter Instagram Youtube